(Q36787659)

16 August 2017

1 reference

title

Recent advances in community-acquired pneumonia: inpatient and outpatient (English)

1 reference

16 August 2017

Michael S Niederman

1

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 April 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

131

1 reference

16 August 2017

issue

4

1 reference

16 August 2017

page(s)

1205-1215

1 reference

Telithromycin: a ketolide antibiotic for treatment of respiratory tract infections

16 August 2017

cites work

1 reference

12 December 2020

Microbiology of Severe Aspiration Pneumonia in Institutionalized Elderly

1 reference

12 December 2020

The cost of treating community-acquired pneumonia.

1 reference

12 December 2020

Predicting bacteremia in patients with community-acquired pneumonia

1 reference

12 December 2020

Severe community-acquired pneumonia as a cause of severe sepsis: data from the PROWESS study

1 reference

12 December 2020

A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance

1 reference

12 December 2020

Effect of a clinical pathway to reduce hospitalizations in nursing home residents with pneumonia: a randomized controlled trial

1 reference

12 December 2020

Guidelines for the Treatment of Community-acquired Pneumonia

1 reference

12 December 2020

Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study

1 reference

12 December 2020

Prognosis after community-acquired pneumonia in the elderly: a population-based 12-year follow-up study

1 reference

12 December 2020

Validation of a predictive rule for the management of community-acquired pneumonia

1 reference

12 December 2020

Pneumonia: still the old man's friend?

1 reference

12 December 2020

Comparison of levofloxacin and cefotaxime combined with ofloxacin for ICU patients with community-acquired pneumonia who do not require vasopressors

1 reference

12 December 2020

Delayed administration of antibiotics and atypical presentation in community-acquired pneumonia.

1 reference

12 December 2020

Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia

1 reference

12 December 2020

Reactions after 3 or more doses of pneumococcal polysaccharide vaccine in adults in Alaska

1 reference

12 December 2020

Prospective observational study of bacteremic pneumococcal pneumonia: Effect of discordant therapy on mortality

1 reference

12 December 2020

Health-care-associated pneumonia: a new therapeutic paradigm

1 reference

12 December 2020

Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index

1 reference

12 December 2020

In-hospital observation after antibiotic switch in pneumonia: a national evaluation

1 reference

12 December 2020

Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia

1 reference

12 December 2020

Viral community-acquired pneumonia in nonimmunocompromised adults

1 reference

12 December 2020

Antibiotics and pneumonia: is timing everything or just a cause of more problems?

1 reference

12 December 2020

Brief communication: severe hepatotoxicity of telithromycin: three case reports and literature review

1 reference

12 December 2020

Pleuropulmonary complications of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus: importance of treatment with antimicrobials inhibiting exotoxin production

1 reference

12 December 2020

Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes?

1 reference

12 December 2020

Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia

1 reference

12 December 2020

Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study

1 reference

12 December 2020

Antibiotic timing and diagnostic uncertainty in Medicare patients with pneumonia: is it reasonable to expect all patients to receive antibiotics within 4 hours?

1 reference

12 December 2020

Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia

1 reference

12 December 2020

Changing bacteriology of adult community-acquired lung abscess in Taiwan: Klebsiella pneumoniae versus anaerobes

1 reference

12 December 2020

Cost and incidence of social comorbidities in low-risk patients with community-acquired pneumonia admitted to a public hospital.

1 reference

12 December 2020

Diagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unit

1 reference

12 December 2020

Predicting antimicrobial resistance in invasive pneumococcal infections

1 reference

12 December 2020

Value of short-course antimicrobial therapy in community-acquired pneumonia

1 reference

12 December 2020

Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia

1 reference

12 December 2020

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

1 reference

12 December 2020

An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome

1 reference

12 December 2020

Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study

1 reference

12 December 2020

Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia

1 reference

12 December 2020

Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes

1 reference

12 December 2020

High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm

1 reference

12 December 2020

Combining information from prognostic scoring tools for CAP: an American view on how to get the best of all worlds.

1 reference

12 December 2020

Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy

1 reference

12 December 2020

A randomized trial comparing the cardiac rhythm safety of moxifloxacin vs levofloxacin in elderly patients hospitalized with community-acquired pneumonia

1 reference

12 December 2020

Outpatient gatifloxacin therapy and dysglycemia in older adults

1 reference

12 December 2020

Identifiers

DOI

10.1378/CHEST.06-1994

1 reference

16 August 2017

1 reference